CG Oncology, Inc. (NASDAQ:CGON) Receives $63.88 Consensus Price Target from Analysts
CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ten brokerages that are covering the firm, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 year price […]
CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ten brokerages that are covering the firm, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 year price […]
